2020 American Transplant Congress
Geographic Variation in Listing for Kidney Transplantation: A State-Level Assessment of Access among Patients with End-Stage Renal Disease in the United States
University of Alabama at Birmingham, Birmingham, AL
*Purpose: Barriers to deceased donor kidney transplantation (DDKT) exist, including referral for transplant and waitlist addition, which may vary regionally. The objective of this study…2020 American Transplant Congress
Determinants of Cardiovascular Benefit Observed in a Population with a Functioning Renal Transplant versus Patients Undergoing Chronic Dialysis
Nephrology, CEMIC, Caba, Argentina
*Purpose: Patients (pts) with end stage renal disease have a high morbidity and mortality rate, mostly due to cardiovascular events (CV). Transplantation (Tx) improves survival…2020 American Transplant Congress
Early Impact of Interleukin-6 Blockade on the Distribution of Peripheral Blood Immune Cell Subpopulations – 3-Month Results of a Phase 2 Trial Evaluating Clazakizumab in Late Antibody-Mediated Rejection
*Purpose: Interleukin-6 (IL-6) is considered to play a critical role within the multifacted pathophysiological process of antibody-mediated rejection (ABMR), including modulation of regulatory T cells…2020 American Transplant Congress
The Evolution of Renal Graft Failure Risk: The Power of the Proximal
1Angion Biomedica, San Francisco, CA, 2Columbia University Medical Center, New York, NY
*Purpose: Our goal was to examine the association of eGFR in the first year on long term outcomes following kidney transplant.*Methods: The sample included kidney…2020 American Transplant Congress
Evaluation of Leukopenia and Neutropenia Incidence, Treatment, and Clinical Response in Kidney and Liver Transplant Recipients
Hartford Hospital, Hartford, CT
*Purpose: The purpose is to evaluate incidence, recurrence, therapy modifications, and complications of leukopenia and neutropenia (LN) in kidney (KTR) and liver transplant (LTR) recipients.*Methods:…2020 American Transplant Congress
Real-World Experiences in the Transplantation of Hepatitis C Positive Kidneys
*Purpose: With advancements of direct-acting antivirals, transplantation of HCV-NAT+ (HCV+) organs to HCV-negative (HCV-) recipients has been used to decrease wait times without apparent sacrifice…2020 American Transplant Congress
Barriers for Kidney Transplant Evaluation among People Living with HIV and End-Stage Renal Disease in Mississippi
*Purpose: The number of Kidney transplants (KTx) among people living with HIV (PLWH) who develop end-stage renal disease (ESRD) has been increasing in many transplant…2020 American Transplant Congress
The Use of dd-cfDNA as a Predictive Tool for Future Proteinuria
*Purpose: Most allografts with proteinuria >1500 mg/dL have new glomerular pathology. In contrast, lower levels of proteinuria are generally associated with non-glomerular, nonspecific histologic changes.…2020 American Transplant Congress
Enough Initial Tacrolimus Blood Concentration is Crucial Even with Additional Everolimus in Corticosteroid Early Withdrawal Regimen for Kidney Transplant Recipients
*Purpose: Everolimus (EVR) in combination with low-dose calcineurin inhibitor has been demonstrated in clinical trials to have comparable efficacy in low immunological risk kidney transplant…2020 American Transplant Congress
Prevalence of Primary Aldosteronism in Kidney Transplant Recipients: A Cross-Sectional Study
University of Wisconsin-Madison, Madison, WI
*Purpose: The prevalence of primary aldosteronism (PA) in the general hypertensive (HTN) population is more than 5%, and substantially higher at 20% in certain high-risk…
- « Previous Page
- 1
- …
- 137
- 138
- 139
- 140
- 141
- …
- 531
- Next Page »